Page last updated: 2024-08-24

lerisetron and Neoplasms

lerisetron has been researched along with Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calvo, R; Gonzalo, A; Jiménez, RM; Lucero, ML; Orjales, A; Raczka, E; Suárez, E; Trocóniz, IF1

Other Studies

1 other study(ies) available for lerisetron and Neoplasms

ArticleYear
Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:5

    Topics: Adult; Antiemetics; Benzimidazoles; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Neoplasms; Orosomucoid; Piperidines; Protein Binding; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serum Albumin

1998